Explore the latest content from across our publications

Log In

Forgot Password?
Create New Account

Loading... please wait

Press Release

EMBARGOED FOR RELEASE UNTIL 4 PM ET, January 26, 2004

Tip Sheet for the January 27, 2004 Neurology Journal

St. Paul, Minn. -

Two studies examine relationship between Alzheimer’s disease and testosterone * In the Baltimore Longitudinal Study of Aging of 574 men, “free” testosterone (or that which is unbound to sex hormone binding globulin) was associated with a decreased risk of Alzheimer’s disease. Watch for a news release from the National Institute of Aging, Doug Dollemore, 301-496-1752, dollemod@nia.nih.gov. * In another study, researchers in Italy found that sex hormone binding globulin was significantly elevated in men and women with Alzheimer’s disease, but total testosterone was normal. * A related editorial by Victor Henderson, MD, MS, and Eva Hogervorst, PhD, at the University of Arkansas for Medical Sciences, raises the question of whether it’s men’s turn for clinical trails of hormone therapy for the primary prevention of Alzheimer’s disease. Multinational study looks at Pain versus Itch In patients with atopic dermatitis, or chronic itch, normally painful stimulation (such as mechanical, electrical or heat) elicited itch symptoms rather than pain. The study showed that noxious stimuli can be perceived as itchy in patients with atopic dermatitis, and that the itch symptom can be induced in healthy subjects by conditioning with histamine. Fat intake and its relationship to dementia explored in Netherlands study Consumption of fatty fish and marine omega-3 polyunsaturated fatty acids were related to a decreased risk of impaired cognitive function and speed, whereas higher dietary cholesterol intake was associated with an increased risk of impaired memory and flexibility in this study involving 1,613 middle-aged subjects. Surgery options for Parkinson’s disease discussed in Patient Page Authored by Adam Blanchette, MA, this month’s “Patient Page” focuses on the results of a study in the January 27 Neurology that explores two of the most common surgical treatments for Parkinson’s disease: unilateral pallidotomy and bilateral subthalamic nucleus deep brain stimulation, and compares the effectiveness of each surgery. The Patient Page will be available for downloading from www.neurology.org on January 27, or can be obtained in advance from AAN media relations staff.

Brain & Life logo

GET A DOSE OF BRAIN HEALTH

Dive into a wealth of information by visiting Brain & Life®, where you can explore the freshest updates, tips, and neurologist expert perspectives on brain disease and preventive brain health.

DISCOVER MORE


Subscribe to our email newsletter

The American Academy of Neurology is the leading voice in brain health. As the world’s largest association of neurologists and neuroscience professionals with more than 44,000 members, the AAN provides access to the latest news, science and research affecting neurology for patients, caregivers, physicians and professionals alike. The AAN’s mission is to enhance member career fulfillment and promote brain health for all. A neurologist is a doctor who specializes in the diagnosis, care and treatment of brain, spinal cord and nervous system diseases such as Alzheimer's disease, stroke, concussion, epilepsy, Parkinson's disease, multiple sclerosis, headache and migraine.

Explore the latest in neurological disease and brain health, from the minds at the AAN at AAN.com or find us on Facebook, X, LinkedIn, Instagram and YouTube.

For More Information*

Email media@aan.com

*While content of the American Academy of Neurology (AAN) press releases is developed by the AAN along with research authors and Neurology® editors, we are unable to provide medical advice to individuals. Please contact your health care provider for questions specific to your individual health history or care. For more resources, visit the AAN's patient and caregiver website, Brain & Life®.